AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 2, Pages 304
Publisher
MDPI AG
Online
2022-01-10
DOI
10.3390/cancers14020304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic Effect of Bazedoxifene and PARP Inhibitor in the Treatment of Ovarian Cancer Regardless of BRCA Mutation
- (2021) RUIJIE ZHANG et al. ANTICANCER RESEARCH
- The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis
- (2021) Phyllis van der Ploeg et al. GYNECOLOGIC ONCOLOGY
- Akt Isoforms: A Family Affair in Breast Cancer
- (2021) Alakananda Basu et al. Cancers
- Biomarkers for Homologous Recombination Deficiency in Cancer
- (2021) Svenja Wagener-Ryczek et al. Journal of Personalized Medicine
- Histological patterns and intra-tumor heterogeneity as prognostication tools in high grade serous ovarian cancers
- (2021) Eros Azzalini et al. GYNECOLOGIC ONCOLOGY
- Cell-stiffness and morphological architectural patterns in clinical samples of high grade serous ovarian cancers
- (2021) Eros Azzalini et al. Nanomedicine-Nanotechnology Biology and Medicine
- Origins and evolution of extreme life span in Pacific Ocean rockfishes
- (2021) Sree Rohit Raj Kolora et al. SCIENCE
- First-line PARP inhibition in ovarian cancer — standard of care for all?
- (2020) Susana N. Banerjee et al. Nature Reviews Clinical Oncology
- Phase I trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and AKT inhibitor capivasertib in patients with BRCA1/2 and non-BRCA1/2 mutant cancers
- (2020) Timothy A. Yap et al. Cancer Discovery
- New approaches for targeting platinum-resistant ovarian cancer
- (2020) Michelle McMullen et al. SEMINARS IN CANCER BIOLOGY
- The Association of Residential Altitude on the Molecular Profile and Survival of Melanoma: Results of an Interreg Study
- (2020) Eleonora De Martino et al. Cancers
- BRCA1 affects the resistance and stemness of SKOV3-derived ovarian cancer stem cells by regulating autophagy
- (2019) Yue You et al. Cancer Medicine
- Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
- (2019) Panagiotis A Konstantinopoulos et al. LANCET ONCOLOGY
- PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
- (2019) Ali S. Alzahrani SEMINARS IN CANCER BIOLOGY
- PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement
- (2019) S. Bonin et al. DISEASE MARKERS
- Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer
- (2018) Lan Ying Li et al. Cancer Research and Treatment
- Epidemiology of ovarian cancer: a review
- (2017) Reid Brett M. et al. Cancer Biology & Medicine
- Akt isoform specific effects in ovarian cancer progression
- (2016) Nicolle M. Linnerth-Petrik et al. Oncotarget
- PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
- (2014) HaiXia Li et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression
- (2014) Nicolle M. Linnerth-Petrik et al. PLoS One
- Targeting Akt3 Signaling in Triple-Negative Breast Cancer
- (2013) Y. R. Chin et al. CANCER RESEARCH
- Haploinsufficiency of Akt1 Prolongs the Lifespan of Mice
- (2013) Aika Nojima et al. PLoS One
- Systemic therapy options in BRCA mutation-associated breast cancer
- (2012) Soley Bayraktar et al. BREAST CANCER RESEARCH AND TREATMENT
- Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells
- (2011) Tiera A. Liby et al. INTERNATIONAL JOURNAL OF CANCER
- Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
- (2011) Robert A Soslow et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Genomic Complexity and AKT Dependence in Serous Ovarian Cancer
- (2011) Aphrothiti J. Hanrahan et al. Cancer Discovery
- Higher random oligo concentration improves reverse transcription yield of cDNA from bioptic tissues and quantitative RT-PCR reliability
- (2009) Ermanno Nardon et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51
- (2008) I. Plo et al. CANCER RESEARCH
- Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer
- (2008) Y. Rebecca Chin et al. CELLULAR SIGNALLING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started